Search - tctmd.com

Displaying 221 - 240 of 279

Sort: Relevancy | Date

Presentation TCT 2013

Medical, Transcatheter and Surgical Therapies for Ischemic MR

Presenter: Gregg Stone

October 30, 2013

Presentation TCT 2013

How Do Different Systems of STEMI Care Attempt to Minimize Total Ischemic Time? United States, Europe, and Asia Practices

Presenter: William French

October 30, 2013

Presentation TCT 2013

Case Presentation: Ischemic MR

Presenter: Puja Parikh

October 30, 2013

News Conference News TCT 2013

TCT Leadership Outlines the State of Intervention

October 30, 2013

News Conference News TCT 2013

ACCESS-EUROPE, EVEREST II Data Support MitraClip in MR

October 30, 2013

Presentation TCT 2013

Serial Applications of MSCs in Ischemic Heart Disease: The RIPASSA Study

Presenter: Henricus Duckers

October 29, 2013

Presentation TCT 2013

Prognostic impact of chronic total occlusion in ischemic heart disease and different age categories - A report from the Swedish Coronary Angiography and Angioplasty Registry

Presenter: Loes Hoebers

October 29, 2013

Presentation TCT 2013

Prognostic impact of chronic total occlusion in ischemic heart disease - A report from the Swedish Coronary Angiography and Angioplasty Registry

Presenter: Truls R?munddal

October 29, 2013

News Conference News TCT 2013

State of the Stent: PCI Future Intact Despite Costs, Sociopolitical Factors

October 29, 2013

News Conference News TCT 2013

Intraprocedural ST Predicts Adverse Short-Term Events

October 29, 2013

Presentation TCT 2013

Quantifying the Quality-of-Life Benefits of PCI in Stable Ischemic Heart Disease

Presenter: John Spertus

October 28, 2013

Presentation TCT 2013

Prognostic Implications of Quantitative Ischemia in Stable Ischemic Heart Disease: Lessons from SPECT, PET, and FFR

Presenter: Leslee Shaw

October 28, 2013

Presentation TCT 2013

Ischemic vs Idiopathic Functional MR: Differences in Pathophysiology, Prognosis and Response to Therapies

Presenter: Blase Carabello

October 28, 2013

News Conference News TCT 2013

Understanding Differences Among New Oral Anticoagulants Should Increase Compliance

October 28, 2013

News Conference News TCT 2013

Long-Term Outcomes, Cost May Influence Use of TAVR in Moderate-Risk Patients

October 28, 2013

News Conference News TCT 2013

Experts Discuss Efficacy, Safety of Watchman Device

October 28, 2013

News Conference News TCT 2013

Efficacy of PFO Closure Still Undetermined

October 28, 2013

News Conference News TCT 2013

ABSORB III and IV Trials Aim to Prove Superiority of BVS

October 28, 2013

Presentation TCT 2013

Remote ischemic preconditioning improves outcome out to 6-years following elective percutaneous coronary intervention: the CRISP-Stent trial.

Presenter: Stephen Hoole, William Watson, Adam Brown, William Davies, David Dutka

January 31, 2013

Presentation TCT 2013

Remote Ischemic Perconditioning Improves Long-Term Clinical Outcome in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction

Presenter: Astrid D Sloth, Michael R Schmidt, Kim Munk, Rajesh K Kharbanda, Andrew N Redington, Lars Pedersen, Henrik T S?rensen, Hans Erik B?tker

January 31, 2013

Advertisement

Medical, Transcatheter and Surgical Therapies for Ischemic MR

How Do Different Systems of STEMI Care Attempt to Minimize Total Ischemic Time? United States, Europe, and Asia Practices

Case Presentation: Ischemic MR

TCT Leadership Outlines the State of Intervention

ACCESS-EUROPE, EVEREST II Data Support MitraClip in MR

Serial Applications of MSCs in Ischemic Heart Disease: The RIPASSA Study

Prognostic impact of chronic total occlusion in ischemic heart disease and different age categories - A report from the Swedish Coronary Angiography and Angioplasty Registry

Prognostic impact of chronic total occlusion in ischemic heart disease - A report from the Swedish Coronary Angiography and Angioplasty Registry

State of the Stent: PCI Future Intact Despite Costs, Sociopolitical Factors

Intraprocedural ST Predicts Adverse Short-Term Events

Quantifying the Quality-of-Life Benefits of PCI in Stable Ischemic Heart Disease

Prognostic Implications of Quantitative Ischemia in Stable Ischemic Heart Disease: Lessons from SPECT, PET, and FFR

Ischemic vs Idiopathic Functional MR: Differences in Pathophysiology, Prognosis and Response to Therapies

Understanding Differences Among New Oral Anticoagulants Should Increase Compliance

Long-Term Outcomes, Cost May Influence Use of TAVR in Moderate-Risk Patients

Experts Discuss Efficacy, Safety of Watchman Device

Efficacy of PFO Closure Still Undetermined

ABSORB III and IV Trials Aim to Prove Superiority of BVS

Remote ischemic preconditioning improves outcome out to 6-years following elective percutaneous coronary intervention: the CRISP-Stent trial.

Remote Ischemic Perconditioning Improves Long-Term Clinical Outcome in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content